Prognostic impact of right ventricular dysfunction following transcatheter mitral valve repair
Running title: Prognostic impact of TAPSE on MitraClip therapy
Shingo Kuwata1, MD; Masaki Izumo1, MD; Noriko Shiokawa2, JRDCS; Yukio Sato1, MD; Ryo Kamijima1, MD; Shunichi Doi1, MD; Haruka Kameshima1, MD; Toshiki Kaihara1, MD; Masashi Koga1, MD; Kazuaki Okuyama1, MD; Yasuhiro Tanabe1, MD; Tomoo Harada1, MD; Yuki Ishibashi1, MD; Yoshihiro J Akashi1, MD
1. Division of Cardiology, Department of Internal Medicine, St. Marianna University School of Medicine
2. Ultrasound Center, St. Marianna University School of Medicine
Address for correspondence:
Shingo Kuwata, MD
Assistant Professor
Division of Cardiology, Department of Internal Medicine, St. Marianna University School of Medicine
2-16-1 Sugao, Miyamae-ku, Kawasaki-city, Kanagawa, Japan
Tel: +81 44 977 8111 Fax: +81 44 976 7093
E-mail: shingo.k.571019@gmail.com
Disclosure of Potential Conflicts of Interest:
Dr. Kuwata and Izumo is a clinical proctor for Abbott Vascular.
The remaining authors have nothing to disclose.
No financial funding, grants, contracts, and any other forms of financial support to be disclosed for the work of this manuscript.
Word count: 3752 words